TickerFactsScreenerDevelopers

Inhibitor Therapeutics, Inc. (INTI) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $1.32M2012: $857.7K2013: $2172014: $365.2K2015: $601.4K2016: $6.89M2017: $344.1K2018: $1.11M2019: $803.8K2020: $75.1K2021: $30.6K2022: $11.95M2023: $8.84M2024: $5.61M2025: $2.38M$2.38M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$2.38M-57.6%
2024$5.61M-36.6%
2023$8.84M-26.0%
2022$11.95M+38923.1%
2021$30.6K-59.2%
2020$75.1K-90.7%
2019$803.8K-27.5%
2018$1.11M+222.2%
2017$344.1K-95.0%
2016$6.89M+1044.8%
2015$601.4K+64.7%
2014$365.2K+168177.0%
2013$217-100.0%
2012$857.7K-35.1%
2011$1.32M—